A distinct subgroup with Schwann-like differentiation presents immune resistance and poor prognosis in plantar melanoma
Theranostics · 2025
DOI: 10.7150/thno.99526 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Jie Tian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Melanoma, Schwann Cells, Skin Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China.
- Institute of Medical Technology, Peking University Health Science Center, Beijing, China.
- Biomedical Engineering Department, Institute of Advanced Clinical Medicine, Peking University, Beijing, China.
- National Clinical Research Center for Skin and Immune Diseases, Beijing, China.
- Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China.
- NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China.
Zitieren
APA
Tian, J., Zhang, L., Zhuang, L., Lin, P., Zhang, S., Yan, Y., Yang, Y., Zhang, G., Li, H., & Lai, B. (2025). A distinct subgroup with Schwann-like differentiation presents immune resistance and poor prognosis in plantar melanoma. Theranostics. https://doi.org/10.7150/thno.99526
Vancouver
Tian J, Zhang L, Zhuang L, Lin P, Zhang S, Yan Y, et al. A distinct subgroup with Schwann-like differentiation presents immune resistance and poor prognosis in plantar melanoma. Theranostics. 2025. doi:10.7150/thno.99526
BibTeX
@article{Tian2025,
author = {Tian, Jie and Zhang, Lu and Zhuang, Le and Lin, Pingping and Zhang, Shenxi and Yan, Yicen and Yang, Yu and Zhang, Guohong and Li, Hang and Lai, Binbin},
title = {A distinct subgroup with Schwann-like differentiation presents immune resistance and poor prognosis in plantar melanoma},
journal = {Theranostics},
year = {2025},
doi = {10.7150/thno.99526}
}
EUVIMED